HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Understanding the burden of pneumococcal disease in adults.

Abstract
Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30% of cases. Streptococcus pneumoniae is gaining resistance to the in vitro activity of several antimicrobial agents and, even if questions remain regarding the clinical impact of this phenomenon, more and more reports indicate that antibiotic resistance can lead to more treatment failures if not higher mortality. Use of the 23-valent anti-pneumococcal vaccine appears to offer subpotimal protection against pneumococcal disease, particularly among high-risk adult populations. Vaccination against S. pneumoniae with new conjugate vaccines seems to be the most promising field for real improvement in the management of pneumococcal infections in adults.
AuthorsF Blasi, M Mantero, PierAchille Santus, P Tarsia
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 18 Suppl 5 Pg. 7-14 (Oct 2012) ISSN: 1469-0691 [Electronic] England
PMID22882668 (Publication Type: Journal Article, Review)
Copyright© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • 23-valent pneumococcal capsular polysaccharide vaccine
  • Anti-Bacterial Agents
  • Pneumococcal Vaccines
Topics
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Bacteremia (drug therapy, epidemiology, prevention & control)
  • Community-Acquired Infections (drug therapy, epidemiology, prevention & control)
  • Drug Resistance, Bacterial
  • Humans
  • Pneumococcal Infections (drug therapy, epidemiology, prevention & control)
  • Pneumococcal Vaccines (administration & dosage, immunology)
  • Streptococcus pneumoniae (drug effects)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: